Agonists for the Chemokine Receptor CXCR4

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Chemokine receptor CXCR4 is a therapeutic target.
• Previous models suggest specific interaction sites for chemokine-receptor binding.

Purpose of the Study:

• To design and synthesize novel high-affinity agonists for CXCR4.
• To investigate the structure-activity relationship of chimeric peptides based on SDF-1 and T140.

Main Methods:

• Peptide synthesis: Grafting the agonistic N-terminus of SDF-1 onto the T140 backbone at specific positions (e.g., 12 and 14).
• Binding affinity assays to determine the nanomolar affinity of the synthesized chimeras for CXCR4.
• Chemotactic assays to evaluate the agonist activity of the chimeras.

Main Results:

• Chimeras with SDF-1 N-terminus grafted to T140 position 14 exhibited partial agonist activity.
• One chimera demonstrated full CXCR4 agonism with a binding affinity of 25 nM.
• Several other chimeras displayed low nanomolar affinities and partial agonist effects.

Conclusions:

• The study successfully developed high-affinity CXCR4 agonists.
• Grafting the SDF-1 N-terminus to the T140 backbone, particularly at position 14, is a viable strategy for creating potent CXCR4 agonists.